JP2009528065A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009528065A5 JP2009528065A5 JP2008557419A JP2008557419A JP2009528065A5 JP 2009528065 A5 JP2009528065 A5 JP 2009528065A5 JP 2008557419 A JP2008557419 A JP 2008557419A JP 2008557419 A JP2008557419 A JP 2008557419A JP 2009528065 A5 JP2009528065 A5 JP 2009528065A5
- Authority
- JP
- Japan
- Prior art keywords
- polynucleotide
- seq
- acta
- listeria bacterium
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77847106P | 2006-03-01 | 2006-03-01 | |
| US60/778,471 | 2006-03-01 | ||
| US78457606P | 2006-03-21 | 2006-03-21 | |
| US60/784,576 | 2006-03-21 | ||
| US11/396,216 US20070207171A1 (en) | 2006-03-01 | 2006-03-30 | Engineered listeria and methods of use thereof |
| US11/396,216 | 2006-03-30 | ||
| US11/395,197 US7935804B2 (en) | 2006-03-01 | 2006-03-30 | Engineered Listeria and methods of use thereof |
| US11/395,197 | 2006-03-30 | ||
| PCT/US2007/005457 WO2007103225A2 (en) | 2006-03-01 | 2007-03-01 | Engineered listeria and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009528065A JP2009528065A (ja) | 2009-08-06 |
| JP2009528065A5 true JP2009528065A5 (https=) | 2010-04-15 |
| JP5347135B2 JP5347135B2 (ja) | 2013-11-20 |
Family
ID=38475431
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008557419A Expired - Fee Related JP5347135B2 (ja) | 2006-03-01 | 2007-03-01 | 遺伝子工学操作されたｌｉｓｔｅｒｉａおよびその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| EP (2) | EP2860253B1 (https=) |
| JP (1) | JP5347135B2 (https=) |
| DK (1) | DK1991263T3 (https=) |
| ES (1) | ES2532942T3 (https=) |
| GB (1) | GB2451014B (https=) |
| PT (1) | PT1991263E (https=) |
| SI (1) | SI1991263T1 (https=) |
| WO (1) | WO2007103225A2 (https=) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9012141B2 (en) | 2000-03-27 | 2015-04-21 | Advaxis, Inc. | Compositions and methods comprising KLK3 of FOLH1 antigen |
| US7935804B2 (en) | 2006-03-01 | 2011-05-03 | Aduro Biotech | Engineered Listeria and methods of use thereof |
| US20110129499A1 (en) * | 2008-05-19 | 2011-06-02 | Paulo Maciag | Dual delivery system for heterologous antigens |
| US9650639B2 (en) | 2008-05-19 | 2017-05-16 | Advaxis, Inc. | Dual delivery system for heterologous antigens |
| US9017660B2 (en) | 2009-11-11 | 2015-04-28 | Advaxis, Inc. | Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors |
| US10016617B2 (en) | 2009-11-11 | 2018-07-10 | The Trustees Of The University Of Pennsylvania | Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers |
| JP5977737B2 (ja) * | 2010-05-23 | 2016-08-24 | アデュロ バイオテック | 癌の補助薬物療法でリステリアを使用する方法および組成物 |
| WO2012138377A2 (en) | 2010-10-01 | 2012-10-11 | Trustees Of The University Of Pennsylvania | The use of listeria vaccine vectors to reverse vaccine unresponsiveness in parasitically infected individuals |
| SMT201800444T1 (it) * | 2010-11-17 | 2018-09-13 | Aduro Biotech Inc | Metodi e composizioni per indurre una risposta immunitaria contro egfrviii |
| CA2829960A1 (en) | 2011-03-11 | 2012-09-20 | John Rothman | Listeria-based adjuvants |
| WO2013138337A1 (en) | 2012-03-12 | 2013-09-19 | Advaxis | Suppressor cell function inhibition following listeria vaccine treatment |
| KR20150084033A (ko) * | 2012-11-06 | 2015-07-21 | 아두로 바이오테크, 인코포레이티드 | 조건적으로 약독화된 박테리아 종 그리고 이의 제조 방법 및 이의 용도 |
| SG10201700916SA (en) * | 2012-12-27 | 2017-03-30 | Aduro Biotech Inc | Signal peptide fusion partners facilitating listerial expression of antigenic sequences and methods of preparation and use thereof |
| WO2016061115A1 (en) | 2014-10-13 | 2016-04-21 | Providence Health & Services-Oregon D/B/A Providence Portland Medical Center | Bacterial vaccines deficient in the 2-c-methyl-d-erythritol-4-phosphate pathway and methods of preparation and use thereof |
| MX2017013174A (es) * | 2015-04-13 | 2018-04-11 | Aduro Biotech Inc | Fusiones de variante iii del receptor de factor de crecimiento epidermico-mesotelina y métodos para usar los mismos. |
| CA2982543A1 (en) | 2015-04-13 | 2016-10-20 | Aduro Biotech, Inc. | Immunogenic fusion proteins for the treatment of cancer |
| EP3313418B1 (en) | 2015-06-26 | 2024-03-13 | Cerus Corporation | Cryoprecipitate compositions and methods of preparation thereof |
| CA3003097A1 (en) | 2015-10-23 | 2017-04-27 | Cerus Corporation | Plasma compositions and methods of use thereof |
| ES2970865T3 (es) | 2015-12-16 | 2024-05-31 | Gritstone Bio Inc | Identificación, fabricación y uso de neoantígenos |
| US11155617B2 (en) | 2016-06-23 | 2021-10-26 | Jiangsu Hengrui Medicine Co., Ltd. | LAG-3 antibody, antigen-binding fragment thereof, and pharmaceutical application thereof |
| US20190369087A1 (en) | 2016-12-23 | 2019-12-05 | Cerus Corporation | Systems and methods for testing and screening using compound bound substrates |
| CA3055203A1 (en) | 2017-03-03 | 2018-09-07 | Cerus Corporation | Kits and methods for preparing pathogen-inactivated platelet compositions |
| EP4576103A3 (en) | 2017-10-10 | 2025-08-27 | Gritstone bio, Inc. | Neoantigen identification using hotspots |
| CN111630602A (zh) | 2017-11-22 | 2020-09-04 | 磨石肿瘤生物技术公司 | 减少新抗原的接合表位呈递 |
| WO2019118760A1 (en) * | 2017-12-13 | 2019-06-20 | Inovio Pharmaceuticals, Inc. | Cancer vaccines targeting mesothelin and uses thereof |
| AU2018395525B2 (en) | 2017-12-29 | 2023-09-14 | Cerus Corporation | Systems and methods for treating biological fluids |
| US12011510B2 (en) | 2019-06-22 | 2024-06-18 | Cerus Corporation | Biological fluid treatment systems |
| JP7571063B2 (ja) | 2019-06-22 | 2024-10-22 | シーラス コーポレイション | 生物学的流体の処理を実施するシステム及び方法 |
| CN114269394A (zh) | 2019-06-28 | 2022-04-01 | 塞鲁斯公司 | 用于实现生物流体处理装置的系统和方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6551784B2 (en) | 1989-06-07 | 2003-04-22 | Affymetrix Inc | Method of comparing nucleic acid sequences |
| US5571702A (en) | 1991-03-29 | 1996-11-05 | Genentech, Inc. | Amplification method for detection of human PF4A receptors |
| IT1262895B (it) | 1992-03-02 | 1996-07-22 | Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico. | |
| IL107366A (en) | 1992-10-23 | 2003-03-12 | Chugai Pharmaceutical Co Ltd | Genes coding for megakaryocyte potentiator |
| US6379943B1 (en) | 1999-03-05 | 2002-04-30 | Merck & Co., Inc. | High-efficiency Cre/loxp based system for construction of adenovirus vectors |
| US7662396B2 (en) * | 2001-03-26 | 2010-02-16 | The Trustees Of The University Of Pennsylvania | Compositions and methods for enhancing the immunogenicity of antigens |
| WO1997003715A1 (en) | 1995-07-21 | 1997-02-06 | The General Hospital Corporation | Method and apparatus of enhancing the delivery of a pharmaceutical formulation |
| ATE254931T1 (de) | 1996-01-05 | 2003-12-15 | Us Gov Health & Human Serv | Mesothelinantigen, verfahren und testsatz zur targetierung |
| US6809184B1 (en) | 1997-12-01 | 2004-10-26 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Antibodies, including FV molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use |
| AU2001255196A1 (en) * | 2000-03-29 | 2001-10-08 | The Trustees Of The University Of Pennsylvania | Compositions and methods for enhancing immunogenicity of antigens |
| US6855320B2 (en) * | 2000-03-29 | 2005-02-15 | The Trustees Of The University Of Pennsylvania | Fusion of non-hemolytic, truncated form of listeriolysin O to antigens to enhance immunogenicity |
| JP2004503512A (ja) | 2000-06-09 | 2004-02-05 | アメリカ合衆国 | 免疫複合体の抗腫瘍活性を改善し、かつ、毒性を低減するリンカーのｐｅｇ化 |
| US7425449B2 (en) | 2002-04-30 | 2008-09-16 | The Regents Of The University Of California | Site specific Listeria integration vectors and methods for using the same |
| KR101192652B1 (ko) | 2003-02-06 | 2012-10-19 | 앤저 테라퓨틱스 인코퍼레이티드 | 비포식 세포로의 침투가 약화된 리스테리아, 리스테리아를 포함하는 백신, 및 그것의 사용방법 |
| KR101173871B1 (ko) | 2003-02-06 | 2012-08-16 | 앤저 테라퓨틱스 인코퍼레이티드 | 변형된 독립생존 미생물, 백신 조성물 및 그것의 사용방법 |
| US20050147621A1 (en) | 2003-10-10 | 2005-07-07 | Higgins Darren E. | Use of bacterial 5' untranslated regions for nucleic acid expression |
| EP1682173A4 (en) | 2003-10-15 | 2007-10-31 | Medimmune Inc | EPHA2 VACCINE ON LISTERIA BASE |
| US7842289B2 (en) | 2003-12-24 | 2010-11-30 | Aduro Biotech | Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof |
| EP1708741B1 (en) * | 2003-12-24 | 2016-03-30 | Aduro Biotech | Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of use thereof |
| PT2942391T (pt) * | 2004-08-13 | 2018-10-09 | Univ Pennsylvania | Métodos de produção de vacinas não resistentes aos antibióticos |
| WO2006017857A2 (en) * | 2004-08-13 | 2006-02-16 | The Trustees Of The University Of Pennsylvania | Antibiotic resistance free dna vaccines |
-
2007
- 2007-03-01 EP EP14193181.6A patent/EP2860253B1/en not_active Not-in-force
- 2007-03-01 JP JP2008557419A patent/JP5347135B2/ja not_active Expired - Fee Related
- 2007-03-01 SI SI200731608T patent/SI1991263T1/sl unknown
- 2007-03-01 GB GB0817892A patent/GB2451014B/en not_active Expired - Fee Related
- 2007-03-01 ES ES07752174.8T patent/ES2532942T3/es active Active
- 2007-03-01 WO PCT/US2007/005457 patent/WO2007103225A2/en not_active Ceased
- 2007-03-01 EP EP07752174.8A patent/EP1991263B8/en not_active Not-in-force
- 2007-03-01 PT PT07752174T patent/PT1991263E/pt unknown
- 2007-03-01 DK DK07752174T patent/DK1991263T3/en active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009528065A5 (https=) | ||
| Ridpath et al. | Delayed onset postvaccinal mucosal disease as a result of genetic recombination between genotype 1 and genotype 2 BVDV | |
| ES2255181T3 (es) | Antigeno inmunoprotector contra la gripe y su uso en vacunacion. | |
| JP2011529077A (ja) | Ｃ型肝炎の治療のための組成物および方法 | |
| JP2014504851A5 (https=) | ||
| JP2013526837A5 (https=) | ||
| JP2022534282A5 (https=) | ||
| JP2017513502A5 (https=) | ||
| JP2020520662A5 (https=) | ||
| CN1251042A (zh) | 广泛反应性的dr限制性表位的鉴定 | |
| CN112063592A (zh) | 非洲猪瘟多基因联合缺失减毒株的构建及作为疫苗的应用 | |
| JP2012516140A5 (https=) | ||
| JP2005509420A5 (https=) | ||
| JP6313215B2 (ja) | 組み換え酵母を用いた、定義された抗原に対する防御的体液性免疫応答の生成による予防接種 | |
| CN100471957C (zh) | 用于免疫治疗的腺病毒载体 | |
| JP6213969B2 (ja) | 免疫原性ポリペプチド表層発現ビフィズス菌 | |
| EP2483409B1 (en) | LACTOBACILLUS glyceraldehyde-3-phosphate dehydrogenase PROMOTERS AND USES THEREOF | |
| US20160324954A1 (en) | Immunogenic compositions for inhibiting hepatitis d virus | |
| CN111683679A (zh) | 具有异源抗原的活的减毒黄病毒 | |
| CN1471580A (zh) | 含有外源性内表位的病毒颗粒 | |
| JP2007518405A5 (https=) | ||
| Saini et al. | High-level synthesis of Johnson grass mosaic virus coat protein in Escherichia coli and its auto-assembly to form virus-like particles | |
| WO2004096288A2 (es) | Método para la obtencion de minicírculos replicativos de adn para transferencia génica o como inmunomoduladores. | |
| CN101406698B (zh) | 展示狂犬病病毒保护性抗原的犬ⅱ型腺病毒活载体重组疫苗 | |
| Anwar et al. | Construction and expression of indonesian hepatitis B core antigen (HBcAg) in Lactococcus lactis as potential therapeutic vaccine |